当前位置:首页 - 行情中心 - 凯普生物(300639) - 财务分析 - 现金流量表

凯普生物

(300639)

  

流通市值:35.19亿  总市值:35.82亿
流通股本:6.35亿   总股本:6.47亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金693,484,670.77445,799,579.1230,220,258.291,028,859,142.74
  收到的税费返还121,212.14121,127.624,118.5812,651,730.79
  收到其他与经营活动有关的现金20,518,823.6416,745,086.3811,788,058.5734,013,120.44
  经营活动现金流入小计714,124,706.55462,665,793.1242,012,435.441,075,523,993.97
  购买商品、接受劳务支付的现金139,627,738.394,681,292.743,192,726.9170,725,614.95
  支付给职工以及为职工支付的现金245,123,058.88170,111,506.1788,467,544.45380,422,590.77
  支付的各项税费37,743,624.1923,459,508.537,351,405.53129,876,330.05
  支付其他与经营活动有关的现金170,419,884.97119,009,885.4656,082,761.06315,721,006.69
  经营活动现金流出小计592,914,306.34407,262,192.86195,094,437.94996,745,542.46
  经营活动产生的现金流量净额121,210,400.2155,403,600.2446,917,997.578,778,451.51
二、投资活动产生的现金流量:
  收回投资收到的现金658,000,102.76405,000,102.76116,000,102.76694,414,259.16
  取得投资收益收到的现金1,887,967.821,309,106.63877,983.34-
  处置固定资产、无形资产和其他长期资产收回的现金净额605,350601,83838398,798.64
  投资活动现金流入小计660,493,420.58406,911,047.39116,878,124.1694,813,057.8
  购建固定资产、无形资产和其他长期资产支付的现金48,444,840.5732,087,894.9215,892,794.73148,332,554.69
  投资支付的现金631,500,000116,000,000116,000,000656,830,239.79
  取得子公司及其他营业单位支付的现金5,700,000---
  投资活动现金流出小计685,644,840.57148,087,894.92131,892,794.73805,162,794.48
  投资活动产生的现金流量净额-25,151,419.99258,823,152.47-15,014,670.63-110,349,736.68
三、筹资活动产生的现金流量:
  吸收投资收到的现金8,000,0008,000,0008,000,000-
  其中:子公司吸收少数股东投资收到的现金8,000,0008,000,0008,000,000-
  取得借款收到的现金46,000,00045,000,00045,000,00055,318,592
  筹资活动现金流入小计54,000,00053,000,00053,000,00055,318,592
  偿还债务支付的现金23,035,1922,475,400011,617,500
  分配股利、利润或偿付利息支付的现金3,032,190.391,576,370.55180,774.9944,458,297.57
  其中:子公司支付给少数股东的股利、利润--0-
  支付其他与筹资活动有关的现金104,708,934.93102,129,656.9868,517,304.0974,511,344.48
  筹资活动现金流出小计130,776,317.32106,181,427.5368,698,079.08130,587,142.05
  筹资活动产生的现金流量净额-76,776,317.32-53,181,427.53-15,698,079.08-75,268,550.05
四、汇率变动对现金及现金等价物的影响3,388,635.5-3,176,317.34-1,261,977.637,587,913.7
五、现金及现金等价物净增加额22,671,298.4257,869,007.8414,943,270.16-99,251,921.52
  加:期初现金及现金等价物余额662,115,776.09662,115,776.09672,218,393.15761,367,697.61
  期末现金及现金等价物余额684,787,074.49919,984,783.93687,161,663.31662,115,776.09
补充资料:
  净利润--137,116,800.36--950,350,169.79
  资产减值准备-68,458,178.12-645,751,881.06
  固定资产和投资性房地产折旧-65,265,442.69-147,747,213.17
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-65,265,442.69-147,747,213.17
  无形资产摊销-6,738,050.65-12,763,125.08
  长期待摊费用摊销-14,995,090.89-28,627,058.54
  处置固定资产、无形资产和其他长期资产的损失--358,182.51-248,851.5
  固定资产报废损失-157,863.35-668,788.92
  公允价值变动损失--4,438,941.3--4,050,096
  财务费用--12,901,290.18-1,253,032.7
  投资损失-593,740.04--5,153,928.52
  递延所得税-7,062,072.76-114,491,878.05
  其中:递延所得税资产减少-12,384,607.7-109,024,753.4
    递延所得税负债增加--5,322,534.94-5,467,124.65
  存货的减少--4,523,876.37-18,164,322.57
  经营性应收项目的减少-81,525,773.55-161,222,708.53
  经营性应付项目的增加--29,294,125.51--113,454,976.5
  其他--3,852,064.3-11,594,018.73
  现金的期末余额-919,984,783.93-662,115,776.09
  减:现金的期初余额-662,115,776.09-761,367,697.61
  现金及现金等价物的净增加额-257,869,007.84--99,251,921.52
公告日期2025-10-292025-08-262025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑